Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OLMA stock hub

Olema Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OLMAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.3B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

OLMA

In the news

Latest news · OLMA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-36.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-23.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OLMA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001750284
Company name	Olema Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	68062P106
Employees	131
Employees Change	35%
Employees Change Percent	36.46
Enterprise value	$800.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-11-19
Isin	US68062P1066
Last refreshed	2026-05-10
Market cap	$1.3B
Market cap category	Small-Cap
Price	$14.9
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	OLMA
Website	https://olema.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.48%
FCF yield	-11.27%
P/B ratio	2.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-162.5M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-21.42
Roa5y	-22.35
ROCE	-35.03
ROE	-36.61
Roe5y	-36.96
ROIC	-23.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	222.07%
Cagr3y	30.78%
Cagr5y	-7.16%
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$533.4M
Cash	$505.4M
Current Assets	$515.5M
Current Liabilities	$51.8M
Debt	$4.2M
Debt Equity	$0.01
Equity	$478.6M
Liabilities	$54.9M
Long Term Assets	$18M
Long Term Liabilities	$3.1M
Net Cash	$501.2M
Net Cash By Market Cap	$38.51
Net Cash Growth	15.85%
Net Debt Equity	$-1.05
Tangible Book Value	$478.6M
Tangible Book Value Per Share	$5.88
WACC	15.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.95
Net Working Capital	$-40.7M
Quick ratio	9.84
Working Capital	$463.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-48.11%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	221.81%
200-day SMA	16.13
3Y total return	123.72%
50-day SMA	16.18
50-day SMA vs 200-day SMA	50over200
5Y total return	-31.02%
All Time High	60.27
All Time High Change	-75.28%
All Time High Date	2020-12-02
All Time Low	2
All Time Low Change	645%
All Time Low Date	2022-05-09
ATR	0.84
Beta	2.06
Beta1y	-1.18
Beta2y	1.05
Ch YTD	-40.4
High	15.47
High52	36.26
High52 Date	2025-12-16
High52ch	-58.91%
Low	14.85
Low52	3.89
Low52 Date	2025-06-13
Low52ch	283.03%
Ma50ch	-7.93%
Premarket Change Percent	0.23
Premarket Price	$15.16
Premarket Volume	1,394
Price vs 200-day SMA	-7.63%
RSI	43.06
RSI Monthly	51.68
RSI Weekly	43.83
Sharpe ratio	1.24x
Sortino ratio	3.79
Total Return	-48.11%
Tr YTD	-40.4
Tr1m	-2.3%
Tr1w	4.05%
Tr3m	-41.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	3
Analyst Price Target Top	$48
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.54
Operating Income	$-168.7M
Price target	$44.89
Price Target Change	$201
Price Target Change Top	$222

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	67,615,308%
Float Percent	77.41%
Net Borrowing	3,000,000
Shares Insiders	2.78%
Shares Institutions	85.48%
Shares Out	87,346,132
Shares Qo Q	6.51%
Shares Yo Y	48.11%
Short Float	19.13%
Short Ratio	8.74
Short Shares	14.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-164.3M
Average Volume	793,966.3x
Bv Per Share	5.88
Ch1m	-2.3
Ch1w	4.05
Ch1y	221.8
Ch3m	-41.25
Ch3y	123.7
Ch5y	-31.02
Ch6m	78.44
Change	-1.52%
Change From Open	-0.6
Close	15.13
Days Gap	-0.93
Depreciation Amortization	490,000
Dollar Volume	8,827,117.6
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-168.7M
EBITDA	$-168.2M
EPS	$-1.87
F Score	1
FCF	$-146.7M
FCF EV Yield	-18.33x
FCF Per Share	$-1.68
Financing CF	211,297,000
Fiscal Year End	December
Founded	2,006
Investing CF	-155,760,000
Ipr	-21.58
Iprfo	-66.89
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-16
Ma150	19.29
Ma150ch	-22.75%
Ma20	15.48
Ma20ch	-3.75%
Net CF	-91,179,000
Next Earnings Date	2026-05-22
Open	14.99
Optionable	Yes
Position In Range	8.06
Post Close	14.9
Postmarket Change Percent	-0.4
Postmarket Price	$14.84
Ppne	1,420,000
Pre Close	15.13
Price Date	2026-05-08
Ptbv Ratio	2.72
Relative Volume	0.75x
Share Based Comp	17,586,000
Tr6m	78.44%
Us State	California
Volume	592,424

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OLMA pay a dividend?

Capital-return profile for this ticker.

Performance

OLMA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OLMA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+85.5%

Float: +77.4% of shares outstanding

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

OLMA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

-7.6%

50/200-day relationship not available

Beta (5Y)

2.06

More volatile than the market

Sharpe ratio

1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OLMA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current OLMA stock rating?

Olema Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full OLMA analysis?

The full report lives at /stocks/OLMA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for OLMA?

The latest report frames OLMA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the OLMA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.